Recent News

• 01.16.2026 - DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 12.18.2025 - DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
• 11.12.2025 - DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
• 11.10.2025 - DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
• 11.06.2025 - DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025

Recent Filings

• 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 8-K Current report
• 12.18.2025 - EX-99.1 EX-99.1
• 12.18.2025 - 8-K Current report
• 12.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 11.12.2025 - EX-99.1 EX-99.1